Peer Review History

Original SubmissionMay 31, 2025
Decision Letter - Abdelfattah Selim, Editor

Dear Dr. Iqbal,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Aug 01 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Abdelfattah Selim, PhD

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following financial disclosure:

“The authors extend their appreciation to the Ongoing Research Funding Program (ORF-2025-971), King Saud University, Riyadh, Saudi Arabia, for funding this research.”

Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

3. Thank you for stating the following in the Acknowledgments Section of your manuscript:

“The authors extend their appreciation to the Ongoing Research Funding Program (ORF-2025-971), King Saud University, Riyadh, Saudi Arabia, for funding this research”

We note that you have provided funding information that is currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

“The authors extend their appreciation to the Ongoing Research Funding Program (ORF-2025-971), King Saud University, Riyadh, Saudi Arabia, for funding this research.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

4. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript.

5. We note that Figure 1 in your submission contain [map/satellite] images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

1. You may seek permission from the original copyright holder of Figure 1 to publish the content specifically under the CC BY 4.0 license. 

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission.

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

2. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

The following resources for replacing copyrighted map figures may be helpful:

USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/

The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/

Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html

NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/

Landsat: http://landsat.visibleearth.nasa.gov/

USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/#

Natural Earth (public domain): http://www.naturalearthdata.com/

6. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: Yes

Reviewer #4: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: Yes

Reviewer #4: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: Yes

Reviewer #4: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: Yes

Reviewer #4: Yes

**********

Reviewer #1: General Evaluation:

This manuscript presents a well-structured and scientifically sound study investigating the prevalence and genetic characterization of three major blood-borne pathogens Anaplasma spp., Anaplasma ovis, and Theileria ovis in sheep populations from six districts of Punjab, Pakistan. The topic is timely, relevant, and important for both veterinary health and livestock productivity, particularly in low-income rural regions where small ruminants play a key role in livelihoods and food security.

The authors have combined molecular techniques, including PCR amplification of 16S rRNA, msp4, and 18S rRNA genes, with phylogenetic analysis to assess pathogen diversity. This approach provides both prevalence data and evolutionary insights that are critical for understanding pathogen ecology and potential disease transmission dynamics in the region.

Strengths of the Manuscript:

Novelty and Regional Relevance:

The study fills an important knowledge gap regarding the epidemiology and molecular diversity of blood-borne pathogens in sheep from Pakistan, a country where such data are limited.

Comprehensive Sampling Strategy:

Sampling across six districts ensures geographic diversity and strengthens the generalizability of findings.

Robust Molecular and Phylogenetic Methods:

The use of highly conserved genetic markers for molecular identification and phylogenetic analysis is appropriate and yields informative results.

Relevant Risk Factor Analysis:

Associations between infection prevalence and factors such as herd size, breed, and geographical location are well-presented and contextualized with previous studies.

Well-Structured Discussion:

The discussion effectively compares local data with global findings, providing valuable insight into the pathogen's prevalence, diversity, and epidemiological trends.

Clear Conclusion and Implications:

The conclusion rightly emphasizes the need for continued surveillance, regional-scale phylogenetic studies, and the development of prevention strategies.

Minor Suggestions for Improvement:

Some grammatical and typographical corrections can improve readability. These are mostly minor and do not affect the scientific content. Figures and tables should be properly formatted according to journal guidelines. For clarity, brief information on the tick vectors present in the sampled regions could be added in future studies to strengthen the host-vector-pathogen relationship

Final Recommendation:

Accept with Minor Revisions

This manuscript makes a valuable contribution to veterinary parasitology and molecular epidemiology. The study is scientifically rigorous, the data are relevant, and the findings provide useful baseline information for future surveillance and control programs. I recommend acceptance after minor editorial revisions.

Reviewer #2: The manuscript reports molecular detection of four pathogens in sheep from six different regions of Pakistan. The authors collected the data and analyzed statistically for its significance regarding sex and geographic region of the sample collection. However, the manuscript suffers with several shortcomings:

1. The criteria for the selection of four pathogens and six geographic regions have not been stated. Why did authors ignore other pathogens and/or regions?

2. How did authors define ‘large herds’ versus ‘small herds?

3. What was the probability of the movement of herds from one region to other region?

4. How did authors calculated sample size? Why the number of samples differed in each district?

5. Method in 2.1 is not supported by the data. There wasn’t a structured epidemiological survey.

6. Method in 2.2 needs critical scrutiny. First, the authors did not use standard or type species as control. Also, the amplicon sizes are too small to assess the results. Have authors provided correct references for these primers? The reference with the doi 10.1016/j.parint.2017.09.002 led to a totally different paper. Other papers are not accessible.

7. How did authors confirm the information given in the lines 194-197.

8. On what basis authors decided to sequence some of the samples and not all? What was the criteria in deciding the number of samples to be sequenced?

9. Information in line 61 is contradictory to the information given in the abstract.

10. There are several language errors including spelling mistakes, formatting issues and redundancy.

Reviewer #3: The article titled "Molecular epidemiology and genetic diversity of Anaplasma and Theileria infections in sheep" by Shahzadi et al. and submitted by Dr. Furhan Iqbal is technically sound and contain important information related to anaplasmosis and theileriosis in sheep of Pakistan. Pakistan being agricultural country with over 70 percent population depends on livestock for their hands to mouth life, this study present important data about livestock parasitic diseases. I will recommend this article for acceptance based on the below mentioned minor edits.

1. Please remove extra information from abstract.

2. Please add more scholarly updated information about the tick borne diseases in Pakistan in the introduction section. This will help improve the rationale part of the introduction.

3. please also clearly mention the gap and need of this study in the last portion of introduction.

4. Please provide a clear map of the study using coordinates of the study area.

5. Results\are well interpreted and presented.

6. Please add some sentences in the discussion portion to make it more interested for the readers.

7. Please revise the conclusion portion based on the results of the study. Also tell the readers about what in future is possible regarding this topic.

Reviewer #4: Dear Authors,

I have reviewed the manuscript titled "Molecular epidemiology and genetic diversity of Anaplasma and Theileria infections in sheep" by Shahzadi et al. Below is my evaluation based on scientific content, language, and adherence to international standards.

Scientific Issues:

1. Title:

- The title is appropriate but could be more concise. Consider: "Molecular Epidemiology and Genetic Diversity of Anaplasma and Theileria spp. in Pakistani Sheep."

2. Abstract:

- The abstract lacks clarity in stating the novelty of the study. The significance of the findings should be emphasized.

- The phrase "phylogenetic evaluation of sp." is unclear and grammatically incorrect.

3. Keywords:

- "Molecular prevalence" is redundant; "Prevalence" suffices.

4. Introduction:

- The economic impact of these infections in Pakistan should be better justified with recent data.

- Some statements lack citations (e.g., "Pakistan is third in the World...").

5. Objectives:

- The aims are clear but could be more explicitly linked to gaps in existing literature.

6. Materials and Methods:

- The sampling strategy (e.g., random vs. convenience sampling) needs clarification.

- PCR conditions (annealing temperatures, cycle numbers) are missing.

- Statistical analysis: Clarify why Fischer’s exact test was used over chi-square for some comparisons.

7. Results:

- Table 1: The co-infection data is useful but should be presented more clearly.

8. Discussion:

- The discussion compares findings well but overstates some conclusions (e.g., genetic similarities with global strains without deeper analysis).

- The absence of Theileria lestoquardi should be discussed in the context of regional vector ecology.

Suggested Addition to the Discussion Section:

Add the two below citations to the reference list and the discussion.

https://doi.org/10.1016/j.smallrumres.2022.106617

https://doi.org/10.1007/s11250-021-03007-4

Two recent works by Noaman and colleagues provides valuable insights into the epidemiology of tick-borne pathogens in small ruminants.

Overall Assessment:

The manuscript presents valuable data on tick-borne pathogens in Pakistani sheep but requires minor revisions for clarity, grammatical accuracy, and methodological details. The results support the discussion and references need verification.

Recommendation: Accept after minor revisions.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

Reviewer #4: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org

Revision 1

Editor’s comments

PONE-D-25-28992

Molecular epidemiology and genetic diversity of Anaplasma and Theileria infections in sheep

PLOS ONE

Dear Dr. Iqbal,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please include the following items when submitting your revised manuscript:

• A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

• A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

• An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

e look forward to receiving your revised manuscript.

Kind regards,

Abdelfattah Selim, PhD

Academic Editor

PLOS ONE

Response to Editor’s comments

Dear Dr. Abdelfattah Selim, PhD

Academic Editor

PLOS ONE

I hope this letter will find you in the best of your conditions. We are highly grateful that you have kindly provided us an opportunity to revise our manuscript number PONE-D-25-28992 entitled “Molecular epidemiology and genetic diversity of Anaplasma and Theileria infections in sheep". We are also indeed thankful to you and the reviewer for the comments and suggestions that proved to be valuable feedback for us and helped us to significantly improve our manuscript. We believe that the reviewer’s comments can be entertained. So we have responded to all comments of the reviewer in a point wise manner in this letter and updated our manuscript as suggested by the reviewers. We have also extensively revised the manuscript in order to minimize the editing and typological errors and to make the manuscript more clear for the readers. The changes made in the revised manuscript can be seen through the TRACK CHANGES option of MS Word. We are submitting the updated and revised version to be considered for publication in your prestigious journal. Please feel free to contact us, if you have further questions.

Thanking you in anticipation.

With best regards

Furhan Iqbal

Corresponding author

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Response

We have followed the instructions for authors.

2. Thank you for stating the following financial disclosure:

“The authors extend their appreciation to the Ongoing Research Funding Program (ORF-2025-971), King Saud University, Riyadh, Saudi Arabia, for funding this research.”

Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

Response

The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

3. Thank you for stating the following in the Acknowledgments Section of your manuscript:

“The authors extend their appreciation to the Ongoing Research Funding Program (ORF-2025-971), King Saud University, Riyadh, Saudi Arabia, for funding this research”

We note that you have provided funding information that is currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

“The authors extend their appreciation to the Ongoing Research Funding Program (ORF-2025-971), King Saud University, Riyadh, Saudi Arabia, for funding this research.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

Response

We are removing funding statement from manuscript.

4. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript.

Response

Ethical statement is only present in the declaration section.

5. We note that Figure 1 in your submission contain [map/satellite] images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

1. You may seek permission from the original copyright holder of Figure 1 to publish the content specifically under the CC BY 4.0 license.

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission.

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

2. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

The following resources for replacing copyrighted map figures may be helpful:

USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/

The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/

Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html

NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/

Landsat: http://landsat.visibleearth.nasa.gov/

USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/#

Natural Earth (public domain): http://www.naturalearthdata.com/

Response

With reference to Fig 1, map was created by using the software QGIS system software. All the shape file having the administrative, provincial and district bounders was downloaded from the website DIVA-GIS, under the tab Free spatial Data. No need to seek consent from copyright holder as the map in Fig 1 was self-drawn. No Google Maps, Street View or Earth source has been used.

6. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

Response

Captions for your Supporting Information files are present at the end of our manuscript.

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Response

Reference list has been revised carefully.

Reviewers' comments:

Reviewer's Responses to Questions

Reviewer #1:

General Evaluation:

This manuscript presents a well-structured and scientifically sound study investigating the prevalence and genetic characterization of three major blood-borne pathogens Anaplasma spp., Anaplasma ovis, and Theileria ovis in sheep populations from six districts of Punjab, Pakistan. The topic is timely, relevant, and important for both veterinary health and livestock productivity, particularly in low-income rural regions where small ruminants play a key role in livelihoods and food security. The authors have combined molecular techniques, including PCR amplification of 16S rRNA, msp4, and 18S rRNA genes, with phylogenetic analysis to assess pathogen diversity. This approach provides both prevalence data and evolutionary insights that are critical for understanding pathogen ecology and potential disease transmission dynamics in the region.

Strengths of the Manuscript:

Novelty and Regional Relevance:

The study fills an important knowledge gap regarding the epidemiology and molecular diversity of blood-borne pathogens in sheep from Pakistan, a country where such data are limited.

Comprehensive Sampling Strategy:

Sampling across six districts ensures geographic diversity and strengthens the generalizability of findings.

Robust Molecular and Phylogenetic Methods:

The use of highly conserved genetic markers for molecular identification and phylogenetic analysis is appropriate and yields informative results.

Relevant Risk Factor Analysis:

Associations between infection prevalence and factors such as herd size, breed, and geographical location are well-presented and contextualized with previous studies.

Well-Structured Discussion:

The discussion effectively compares local data with global findings, providing valuable insight into the pathogen's prevalence, diversity, and epidemiological trends.

Clear Conclusion and Implications:

The conclusion rightly emphasizes the need for continued surveillance, regional-scale phylogenetic studies, and the development of prevention strategies.

Response

Authors are indeed grateful for your kind words and in-depth review of our manuscripts. We have accepted all the suggested changes and made corrections accordingly. These changes have significantly improved our manuscript. Thank you.

Minor Suggestions for Improvement:

• Some grammatical and typographical corrections can improve readability. These are mostly minor and do not affect the scientific content.

Response

We have extensively revised the manuscript in order to minimize the editing and typological errors and to make the manuscript more clear for the readers. The changes made in the revised manuscript can be seen through the TRACK CHANGES option of MS Word.

• Figures and tables should be properly formatted according to journal guidelines.

Response

We have followed the instructions for the authors for table and figure formatting. Thanks for your kind reminder.

• For clarity, brief information on the tick vectors present in the sampled regions could be added in future studies to strengthen the host-vector-pathogen relationship

Response

Thanks for your suggestion. We have already provided some information regarding the ticks vectors that are associated with the screened pathogens. Following text is present in introduction section;

A variety of Anaplasma species infect sheep including Anaplasma marginale, Anaplasma ovis, Anaplasma phagocytophilum and Anaplasma capra [4]. A variety of ticks species belonging to Haemaphysalis , Ixodes and Rhipicephalus genera are transmit these bacteria to sheep and goats [9].

An apicomplexan parasites Theileria lestoquardi that is transmitted to small ruminants by the Hyalomma sp. ticks causes malignant ovine theileriosis that causes fever, cough, lethargy, lymphadenopathy and weight loss and can lead to mortality in case of severe infection [11].

• Final Recommendation:

Accept with Minor Revisions

This manuscript makes a valuable contribution to veterinary parasitology and molecular epidemiology. The study is scientifically rigorous, the data are relevant, and the findings provide useful baseline information for future surveillance and control programs. I recommend acceptance after minor editorial revisions.

Response

Authors are grateful for your kind recommendation.

Reviewer #2:

• The manuscript reports molecular detection of four pathogens in sheep from six different regions of Pakistan. The authors collected the data and analyzed statistically for its significance regarding sex and geographic region of the sample collection. However, the manuscript suffers with several shortcomings:

Response

Authors are indeed grateful for your kind words and in-depth review of our manuscripts. We have accepted all the suggested changes and made corrections accordingly. These changes have significantly improved our manuscript. Thank you.

1. The criteria for the selection of four pathogens and six geographic regions have not been stated. Why did authors ignore other pathogens and/or regions?

Response

Thanks for your query. We have mentioned in the introduction as well as in the discussion section that limited studies in specific areas have been conducted in Pakistan to report the prevalence of Anaplasma and Theileria species in Pakistani sheep and most of the districts are unexplored. To address this gap, sheep were enrolled from six districts in Punjab (Pakistan) and their blood samples were screened for the DNA of Anaplasma sp., Anaplasma ovis, Theileria ovis and Theileria lestoquardi through PCR and DNA sequencing approach. The pathogens selected for the screening are frequently reported in local small ruminants but sheep from five of the six districts has never been screened for these bacteri

Decision Letter - Abdelfattah Selim, Editor

Molecular epidemiology and genetic diversity of Anaplasma and Theileria infections in sheep

PONE-D-25-28992R1

Dear Dr. Iqbal,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Abdelfattah Selim, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

The authors have thoroughly addressed all reviewer comments and significantly improved the manuscript. I recommend acceptance in its current form.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #1: All comments have been addressed

Reviewer #3: All comments have been addressed

Reviewer #4: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions??>

Reviewer #1: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

Reviewer #1: Thank you for your thorough and thoughtful revision of the manuscript. I have carefully reviewed the revised version and the authors’ responses to the previous comments. I am pleased to note that all the minor concerns raised in the initial review have been fully addressed.

The revised manuscript demonstrates improved clarity, coherence, and scientific rigor. The additional data and explanations provided have significantly strengthened the overall quality and impact of the work. The methods are now clearly described, the figures and tables are appropriate, and the conclusions are well-supported by the results.

Based on the comprehensive revisions and the satisfactory responses to all reviewer comments, I recommend the manuscript be accepted for publication in its current form.

Reviewer #3: All my comments on the previous version is well addressed. Hence, i recommend acceptance of this article.

Reviewer #4: Corrections are acceptable. The authors made all the proofreading and suggestions. Now, the manuscript can be considered for publication in the PLOS ONE as a Research Article.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

Reviewer #3: No

Reviewer #4: No

**********

Formally Accepted
Acceptance Letter - Abdelfattah Selim, Editor

PONE-D-25-28992R1

PLOS ONE

Dear Dr. Iqbal,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Prof Abdelfattah Selim

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .